Clinical Trials Logo

Filter by:
NCT ID: NCT05940714 Recruiting - Clinical trials for Periodontal Diseases

Periodontopathogens of Periodontal Patients

Start date: May 15, 2023
Phase: N/A
Study type: Interventional

Study the presence of periodontal pathogens in a Catalan population with periodontitis and evaluate the influence of an intervention measure on oral hygiene teaching (video)

NCT ID: NCT05940571 Recruiting - Cancer Clinical Trials

First Phase Clinical Trial of Single Agent MBF-362 in Solid Tumors

Start date: November 24, 2022
Phase: Phase 1
Study type: Interventional

This is an open, single center Phase Iclinical trial to evaluate the safety, tolerability, and preliminary efficacy of MBF-362 in patients with solid tumors.

NCT ID: NCT05940558 Recruiting - Crohn Disease Clinical Trials

Safety and Efficacy of MBF-118 in Patients With Crohn Disease

Start date: April 12, 2023
Phase: Phase 2
Study type: Interventional

This is a Phase IIa (proof of concept), single center clinical trial to evaluate the safety and efficacy of daily MBF-118 oral treatment during 28 days in Crohn's disease patients on top of standard of care.

NCT ID: NCT05939986 Not yet recruiting - Anxiety Clinical Trials

A Protocol for a Virtual Reality Exposure Therapy for Fear of Flying.

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

This study aims to assess whether adding vibrotactile stimulation to visual and auditory stimulation increases the efficacy of VRET for FoF treatment. Eighty-four participants (18-65 years old) will be assigned to one of three intervention arms, namely the VRET with multimodal feedback (visual, auditory, and vibrotactile; VRET-M), the VRET with bimodal feedback (visual and auditory; VRET-B), or the imagery exposure treatment (IET) without sensory feedback. FoF-related symptoms (primary outcomes) will be measured administering the Fear of Flying Questionnaire-II (QPV-II), the Fear of Flying Scale (FFS), and the Visual Analogic Scale (VAS-A) before and after eight sessions of treatment, and at six- and 12-month follow-ups. Anxiety and the sense of presence experienced during exposure sessions (secondary outcome measures: VAS-A and VAS-P) will also be assessed. It is expected that participants in the VRET-M group will report a further reduction of FoF-related symptomatology after the treatment and at follow-ups compared to participants in the VRET-B and IET groups. Likewise, participants in the VRET-M group are expected to show higher sense of presence levels during exposure sessions in comparison to participants in the VRET-B and IET groups. It is expected that the IET group will report the lowest level of sense of presence and the poorest outcome after treatment and at follow-ups.

NCT ID: NCT05938842 Recruiting - Multiple Sclerosis Clinical Trials

Study Protocol of Online DBT-Mindfulness Intervention in Multiple Sclerosis

ODMiMS
Start date: October 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test an Online DBT-Mindfulness intervention in people with Multiple Sclerosis. The results of the online DBT-Mindfulness intervention will be compared to an active control group (psychoeducational intervention) to see if they improve her emotion dysregulation and decentering, and consequently, this benefits also improve symptoms like anxiety, depression, distress, fatigue and quality of life in people with MS.

NCT ID: NCT05938751 Completed - Autism Clinical Trials

An Intervention to Promote Self-determination in Young Adults With Autism: the TEAm_YOUNG ADULTS Program

TEAm_YA
Start date: October 15, 2020
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the benefits of a program to develop self-determination in young adults with autism. Being self-determined means acting or causing things to happen in your life. It involves deciding, acting and believing in one-self. The main question this clinical trial aims to answer is: Is the program developed useful to improve self-determination of young adults with autism? Participants will receive a group intervention to support the development of their self-determination-related skills during 20 sessions (1 session/week). Researchers will compare the self-determination outcomes between the group that receives the intervention and another group that is in a waiting list (and will receive the intervention later) to see if the changes are due to the intervention.

NCT ID: NCT05938270 Recruiting - Prostate Cancer Clinical Trials

A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.

ASCERTAIN
Start date: September 21, 2023
Phase: Phase 1
Study type: Interventional

A Study to Investigate the Biological Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate Cancer (ASCERTAIN)

NCT ID: NCT05937750 Recruiting - Clinical trials for Long Term Efficacy and Safety

A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group

PAES-LTFU
Start date: July 3, 2023
Phase: Phase 3
Study type: Interventional

A prospective, post-authorisation long-term follow-up trial of patients previously treated with imlifidase prior to kidney transplantation, including a non-comparative concurrent reference cohort.

NCT ID: NCT05937347 Recruiting - ADHD Clinical Trials

Mindfulness and Cognitive Training Programs for Children With ADHD (the NeuroMind Study)

NeuroMind
Start date: July 20, 2023
Phase: N/A
Study type: Interventional

The present project will evaluate through a Randomized Controlled Trial (RCT) with 5-month follow-up, the efficacy (5-month time horizon), adjunctive to TAU, of three 8-week interventions: a) the Mindfulness for Health program (i. e., M4H), b) a Cognitive Training (CT) program through NeuronUp platform and a program combining both (Mindfulness and Cognitive Training program, i. e., UP4H), a, as compared to TAU, in children (7-12 years old) with ADHD. In order to evaluate stability of clinical changes and to determine the mechanisms of action of the interventions studied, pre-post changes and at 5-months followup after the start of treatment will be evaluated in ADHD symptoms (inattention, hyperactivity, impulsivity), general functioning, clinical global impression, executive functions (verbal fluency, working memory, cognitive flexibility, inhibition), and comorbid symptoms (disruptive behavior, anxiety and depression) along with mindfulness skills. In the field of personalized treatment in ADHD, the design of the present study will also make it possible to establish whether certain baseline psychosocial and clinical characteristics may be associated with short- and medium-term clinical response to each of the treatments studied.

NCT ID: NCT05937035 Recruiting - Block Clinical Trials

Histological and Volumetric Evaluation of Customized Allograft Bone Blocks

Start date: May 25, 2024
Phase: N/A
Study type: Interventional

Customized bone blocks need CBCT and digital software to design the block needed to rehabilitate. Some advantages are reduced surgical time and better adaptation of the graft, leading to less complications. Objectives: The primary aim of this study is to determine the bone regeneration capacity through a histological study and the bone volumetric changes of allograft bone blocks in the posterior site of the mandible. The secondary outcome will be to assess the survival and success rate of dental implants placed in the allograft regenerated area. Materials and Methods: After studying the CBCT to regenerate the posterior sites of the mandible, the investigators will design CAD/CAM freeze- dried bone allograft to fit exactly on the defect morphology that the patients present. A full thickness flap will be released to have a correct access of the defects. The sterile blocks have to fit perfectly on the defect and fixed by screws. Covered with resorbable membranes fixed with pines and suture. 4 months later, 2nd CBCTwill be performed. During the implant surgery, a bone trephine will be removed and sent into a Laboratory to make a histological study of the bone block for histomorphometry. After 3 months, second-stage surgery and healing caps will be placed if needed. Impressions will be taken 2 weeks after to perform the final crowns.